HUM · Humana Inc · Documents

$411.79 -5.63 (-1.35%) At close · Nov 5 Earnings today Play latest call Q2 2026 earnings call transcript

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$50.12B

120.06M

Volume · Nov 5 1.36M Avg daily vol (3M) 1.25M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2023

Mar 8

Proxy statement DEF 14A

Proxy statement

Mar 8

Annual report to holders ARS

Annual report to holders

Mar 8

Proxy statement DEFA14A

Proxy statement

Mar 1

Current report 8-K Events of Feb 27

Entered into a material agreement, Other events

Feb 23

Current report 8-K

Regulation FD disclosure

Feb 16

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $92.87B ▲ 11.8% Net income $2.81B ▼ 4.3% Diluted EPS $22.08 ▼ 2.6%

Feb 1

Earnings call

Q4 2022 earnings call

Feb 1

Current report 8-K

Financial results, Regulation FD disclosure

Jan 9

Current report 8-K

Regulation FD disclosure

2022

Dec 8

Current report 8-K

Charter or bylaw amendment, or fiscal year change

Dec 1

Current report 8-K

Regulation FD disclosure

Nov 22

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Nov 8

Current report 8-K Events of Nov 7

Entered into a material agreement, Other events

Nov 3

Current report 8-K Events of Nov 2

Entered into a material agreement

Nov 2

Earnings call

Q3 2022 earnings call

Nov 2

Current report 8-K

Financial results, Regulation FD disclosure

Nov 2

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $22.8B ▲ 10.2% Net income $1.2B ▼ 21.9% Diluted EPS $9.39 ▼ 20.7%

Sep 15

Current report 8-K Events of Sep 12

Director or officer change, or executive pay, Regulation FD disclosure

Jul 27

Earnings call

Q2 2022 earnings call

Jul 27

Current report 8-K

Financial results, Director or officer change, or executive pay, Regulation FD disclosure

Jul 27

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $23.66B ▲ 14.6% Net income $696M ▲ 18.4% Diluted EPS $5.48 ▲ 20.4%

Jun 21

Current report 8-K Events of Jun 16

Director or officer change, or executive pay

Jun 3

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation

Jun 1

Current report 8-K

Regulation FD disclosure

Apr 27

Earnings call

Q1 2022 earnings call

Apr 27

Current report 8-K

Financial results, Regulation FD disclosure

Apr 27

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $23.97B ▲ 16.0% Net income $930M ▲ 12.3% Diluted EPS $7.29 ▲ 14.1%

Apr 25

Current report 8-K Events of Apr 21

Shareholder vote results

Apr 21

Current report 8-K

Regulation FD disclosure

Mar 23

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Mar 22

Current report 8-K Events of Mar 21

Entered into a material agreement, Other events

Mar 9

Proxy statement DEF 14A Meeting Apr 21, 2022

Proxy statement

Mar 9

Proxy statement DEFA14A

Proxy statement

Mar 1

Current report 8-K Events of Feb 28

Director or officer change, or executive pay, Regulation FD disclosure

Mar 1

Current report 8-K

Director or officer change, or executive pay

Feb 22

Current report 8-K

Entered into a material agreement, Regulation FD disclosure

Feb 17

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $83.06B ▲ 7.7% Net income $2.93B ▼ 12.9% Diluted EPS $22.67 ▼ 10.4%

Feb 11

Current report 8-K Events of Feb 10

New debt or off-balance-sheet obligation

Feb 2

Earnings call

Q4 2021 earnings call

Feb 2

Current report 8-K

Financial results, Regulation FD disclosure, Other events

Jan 12

Current report 8-K Events of Jan 11

Entered into a material agreement

Jan 6

Current report 8-K

Regulation FD disclosure

2021

Dec 1

Current report 8-K

Regulation FD disclosure

Nov 3

Earnings call

Q3 2021 earnings call

Nov 3

Current report 8-K

Financial results, Regulation FD disclosure

Nov 3

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $20.7B ▲ 3.1% Net income $1.53B ▲ 14.3% Diluted EPS $11.84 ▲ 17.8%

Sep 7

Current report 8-K

Regulation FD disclosure

Aug 20

Current report 8-K Events of Aug 19

Director or officer change, or executive pay

Aug 3

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure

Aug 2

Current report 8-K Events of Jul 29

Entered into a material agreement, Other events

Showing 101–150 of 198 documents

Key facts CIK 49071 CUSIP 444859102 13F (30d) 433 filings 394 filers Visit website Investor relations